Platelet Rich Plasma in Hiatal Hernia Repair
Launched by UNIVERSITY OF SOUTHERN CALIFORNIA · Aug 20, 2021
Trial Information
Current as of July 01, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Documented hiatal hernia \> 5cm on preoperative video esophagram or upper endoscopy
- Exclusion Criteria:
- • Non-English speaking patients
- • Prior antireflux surgery
- • Platelet count less than 100,000
- • History of platelet dysfunction
- • Antiplatelet therapy up to ten days prior to surgery
- • Corticosteroids use up to one month before surgery
- • Diabetes
- • Active malignancy or treatment for cancer within the last year
- • Pregnancy or active breastfeeding
- • Active smoking
About University Of Southern California
The University of Southern California (USC) is a prestigious research institution located in Los Angeles, California, known for its commitment to advancing knowledge and innovation in various fields, including medicine and health sciences. As a clinical trial sponsor, USC leverages its extensive resources, interdisciplinary expertise, and state-of-the-art facilities to conduct cutting-edge research aimed at improving patient outcomes and public health. The university fosters collaboration among its diverse faculty and students, ensuring a dynamic environment for the development and implementation of clinical studies that adhere to the highest ethical and scientific standards. Through its clinical trials, USC aims to contribute to the advancement of medical science and the translation of research findings into practical applications that benefit communities locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Newport Beach, California, United States
Los Angeles, California, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials